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RhoGDI Is Required
for Cdc42-Mediated Cellular Transformation
case for all members of the Rho family, the activity and
cellular localization of Cdc42 are regulated by three
classes of proteins: (1) Guanine nucleotide exchange
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Cdc42 and thereby catalyze the GDP-GTP exchangeCornell University
Ithaca, New York 14853 (activation) reaction; (2) GTPase-activating proteins
(GAPs), which stimulate the GTP hydrolytic activity of4 Weis Center for Research
Geisinger Clinic the GTP binding protein; and (3) Guanine nucleotide
dissociation inhibitors (GDIs), which inhibit the dissocia-Danville, Pennsylvania 17822
tion of GDP from Cdc42. The GDIs are typically depicted
as negative regulators of Rho-related GTP binding pro-
teins because of their ability to inhibit GDP dissociationSummary
and thus GDP-GTP exchange [2]. However, RhoGDI-1
(from here on simply referred to as RhoGDI) is capableBackground: Cdc42, a Rho-related small GTP binding
of two other biochemical activities, namely the inhibitionprotein, plays pivotal roles in actin cytoskeletal organi-
of GTP hydrolysis and the release of Rho proteins fromzation, Golgi vesicular trafficking, receptor endocytosis,
membranes [3, 4]. These two additional activities thusand cell cycle progression. However, the target/
raise the interesting possibility that RhoGDI may playeffectors mediating these cellular activities and, in par-
positive roles in signaling by maintaining the GTP bind-ticular, those responsible for Cdc42-mediated cell
ing proteins in an activated (GTP bound) state and bygrowth regulation and transformation are still being de-
mediating their movement between different intracellu-termined. In this study, we set out to examine how the
lar membrane locations.regulatory protein RhoGDI influences the cellular re-
Fluorescence-spectroscopic studies coupled withsponses elicited by activated Cdc42.
three-dimensional structural information have sug-Results: X-ray crystallographic analysis of the Cdc42-
gested that the interaction of Cdc42 with RhoGDI is aRhoGDI complex suggested that arginine 66 of Cdc42
two-step process [5, 6]. The first step represents a rapidis essential for its interaction with RhoGDI. Here we
binding between the Switch II region of Cdc42 and anshow that mutation of either arginine 66 or arginine 68
amino-terminal helical domain of RhoGDI. The secondwithin the Switch II domain of Cdc42 completely abol-
step reflects the removal of Cdc42 from membranesished the binding of Cdc42 to RhoGDI without affecting
after the insertion of the geranyl-geranyl moiety ofthe binding of other known regulators or target/effectors
Cdc42 into a hydrophobic pocket present within an anti-of this GTP binding protein. Introduction of the RhoGDI
parallel -pleated sheet in the carboxyl terminal portionbinding-defective mutation R66A within a constitutively
of RhoGDI [6]. An examination of the structure of theactive Cdc42(F28L) background was accompanied by
Cdc42-RhoGDI complex indicated that arginine resi-changes in cell shape and an accumulation of Cdc42 in
dues at positions 66 and 68 within the Switch II domainthe Golgi when these cells were compared to those
were essential components of the Cdc42-RhoGDI bind-expressing Cdc42(F28L). However, the most striking
ing interface [6]. We mutated these residues in Cdc42change was that unlike Cdc42(F28L), which was able
to examine the biological consequences of disruptingto induce the transformation of NIH 3T3 fibroblasts as
Cdc42-RhoGDI interactions in cells and made the some-assayed by their growth in low serum or their ability to
what unexpected discovery that RhoGDI is required forform colonies in soft-agar, the Cdc42(F28L,R66A) mu-
Cdc42-stimulated cellular transformation.tant was transformation-defective. Likewise, the intro-
duction of RhoGDI siRNA into Cdc42(F28L)-transfected
cells inhibited their transformation.
ResultsConclusions: Taken together, the results reported here
indicate that despite being a negative regulator of Cdc42
Mutation of Either Arginine 66 or Arginine 68activation and GTP hydrolysis, RhoGDI plays an essen-
of Cdc42 Selectively Disrupts Itstial role in Cdc42-mediated cellular transformation.
Interaction with Rho-GDI
A close look at the three dimensional structure of the
Introduction Cdc42-RhoGDI complex [6], as well as the structures
for Cdc42 bound to its GAP and various target/effectors
Cdc42 is a member of the Rho family of GTP binding [7–10], suggested that mutating arginine 66 to an alanine
proteins, which serve as molecular switches transduc- within the canonical Switch II region would allow us to
ing external signals to multiple downstream targets and specifically assess the importance of Cdc42-RhoGDI
giving rise to a variety of cellular responses, including interactions in the cellular responses mediated by
the organization of the actin cytoskeleton, cell cycle Cdc42. We first verified that an R66A mutation, when
progression, cell polarity, and morphology [1]. As is the made within a wild-type Cdc42 background, blocked
the binding of RhoGDI. As shown in Figure 1A, GFP-
tagged (wild-type) Cdc42 could be precipitated with a*Correspondence: rac1@cornell.edu
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Figure 1. The Cdc42(R66A) Mutant Is Specif-
ically Defective in Binding to RhoGDI
(A) Binding assays for GFP-tagged Cdc42
mutants with GST-RhoGDI. COS-7 cells were
transiently transfected with GFP-tagged
Cdc42 or its mutants for 48 hr. The cells were
lysed and incubated with GST-RhoGDI pro-
tein purified from E. coli. The protein was de-
tected by Western blotting with an anti-GFP
monoclonal antibody.
(B) Binding assays for Myc-tagged Cdc42
(F28L) and other Cdc42 mutants with GST-
RhoGDI, GST-ACKCRIB and GST-PAKCRIB.
The GST fusion proteins, immobilized on glu-
tathion-agarose beads, were incubated with
the lysates from COS-7 cells expressing
Cdc42. The bound Cdc42 proteins were de-
tected by Western blotting with an anti-Myc
antibody (9E10).
GST-RhoGDI fusion protein after the addition of glutathi- (F28L,R66A) mutant was completely ineffective in bind-
ing to RhoGDI (lane 5). However, the Cdc42(F28L,R66A)one-agarose beads to COS-7 cells that transiently ex-
pressed wild-type Cdc42, whereas the GFP-Cdc42 protein was as effective as Cdc42(F28L) in binding to
Cdc42 targets that contain CRIB (for Cdc42/Rac-inter-(R66A) mutant was not able to bind to GST-RhoGDI. As
previously reported, we also found that an activated active binding) domains. An example is shown for the
limit Cdc42/Rac binding domain from PAK (GST-PAK-form of Cdc42 (the GTPase-defective Cdc42(Q61L) mu-
tant) was able to bind to GST-RhoGDI [3, 11], whereas CRIB), a serine/threonine kinase-target of Cdc42 and
Rac (compare lanes 10 and 11 in Figure 1B). The samethe nucleotide-depleted Cdc42(T17N) mutant, which
has a high affinity for Dbl and other guanine nucleotide was true when we compared the binding of the
Cdc42(F28L) and Cdc42(F28L,R66A) proteins to the limitexchange factors (GEFs) for Cdc42 [12], showed little
detectable binding to RhoGDI. binding domain of ACK (GST-ACKCRIB), a non-receptor
tyrosine kinase that is a specific target for Cdc42 (seeWe then asked whether the R66A mutation, when
made within the background of a constitutively active lanes 7 and 8 in Figure 1B). We found that, similar to
the case for arginine 66 of Cdc42, changing the arginineform of Cdc42, Cdc42(F28L), which allows the spontane-
ous exchange of GTP for GDP [13], also blocked RhoGDI residue at position 68 to an alanine eliminated the ability
of an activated Cdc42 protein to bind RhoGDI withoutinteractions and/or the binding of activated Cdc42 to
its other known target/effectors. We were especially in- affecting its binding to CRIB-motif containing targets
such as PAK and ACK (data not shown).terested in these questions because we have shown
that Cdc42(F28L) is an extremely valuable mutant for We next set out to make certain that the RhoGDI
binding-defective Cdc42 mutants were able to bind ef-studying the cellular responses elicited by activated
forms of Cdc42. Unlike GTPase-defective Cdc42 mu- fectively to full-length versions of these targets. Figure
2A shows that the Cdc42(F28L,R66A) double mutant,tants, which are toxic to NIH 3T3 cells, the Cdc42(F28L)
mutant can be stably expressed and gives rise to cellular like the Cdc42(F28L) protein, is able to bind to full-length
ACK in cells, whereas wild-type (GDP-bound) Cdc42transformation [13]. The results presented in Figure 1B
(lane 4) show that when HA-tagged Cdc42(F28L) was showed no detectable binding. We have also verified
that the tyrosine kinase activity of ACK2 can be fullytransiently expressed in COS-7 cells, it was able to bind
to a GST-RhoGDI fusion protein, whereas the Cdc42 stimulated by Cdc42(F28L,R66A), as can the serine/thre-
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Figure 2. Examination of How the R66A Mu-
tation Affects Cdc42-Target/Effector Interac-
tions
(A) The interaction of full-length ACK2 with
Cdc42(F28L) and Cdc42(F28L,R66A). Myc-
tagged Cdc42 and HA-tagged ACK2 were co-
transfected in COS-7 cells, and then the cells
were lysed and immunoprecipitated with an
anti-Myc antibody. Coimmunoprecipitated-
ACK2 was detected with anti-HA antibody.
(B) Assays of Cdc42-mediated activation of
the c-Jun kinase (JNK1). COS-7 cells were
transiently transfected with HA-tagged Cdc42
or its mutants, together with flag-tagged JNK.
JNK then was immunoprecipitated from the
cell lysates, and its kinase activity was as-
sayed using GST-c-Jun as a substrate as de-
scribed previously [13, 14].
(C) Assays of the binding of Cdc42 to IQGAP.
HA-tagged Cdc42(F28L) or Cdc42(F28L,R66A)
was transfected and expressed in NIH 3T3
cells and immunoprecipitated via an anti-HA
antibody. Coimmunoprecipitated IQGAP was
detected with an anti-IQGAP antibody [16].
(D) Assays of the binding of Cdc42 to the
-coatomer subunit. The Cdc42 GST fusion
proteins, containing bound GTP in the case
of the Q61L mutant or loaded with GDP or
GTPS as indicated, were immobilized on
glutathione-agarose beads and incubated
with COS-7 cell lysates. Bound coatomer
subunits were blotted with an antibody that
recognizes both the - and -coatomer sub-
units [17].
onine kinase activity of full-length PAK3 (data not were immunoprecipitated). Similar results were ob-
tained from assays of the binding of Cdc42 to theshown). Moreover, as shown in Figure 2B, the Cdc42
(F28L)-stimulated activation of the c-Jun kinase (JNK), -coatomer subunit. Figure 2D shows that a GST fusion
protein encoding the GTP bound, GTPase-defectivewhich results in a 2- to 3-fold increase in JNK activity
in COS-7 cells [13] and requires PAK activation [14], is Cdc42 [Cdc42(Q61L)] as well as the GTPS bound forms
of GST-wild-type Cdc42 and the GST-Cdc42(R66A) mu-unaffected by either the R66A or R68A mutation.
Thus far, we have found the same to be true for other tant all exhibited comparable abilities to bind to the
-coatomer subunit. Other subunits of the COPI com-CRIB-motif-containing Cdc42 targets (e.g., full-length
WASP)—that is, neither the R66A nor the R68A mutation plex (e.g., -coatomer) were also coprecipitated with
each of these versions of activated Cdc42, through theirinterfered with their binding to activated Cdc42. In addi-
tion, this holds for other Cdc42-targets that lack a CRIB association with the -coatomer subunit [13].
Taken together, the results presented in Figures 1 andmotif. The two presently known examples are IQGAP
and the -coatomer subunit of the COPI complex [15– 2 indicate that Switch II point mutations that interfere
with the binding of Cdc42 to RhoGDI do not compromise17]. The former has been implicated in interfacing Cdc42
with the actin cytoskeleton [15, 16], and recent studies the interactions between Cdc42 and its target/effectors.
The fact that Cdc42 Switch II mutations that prevent theperformed in S. cerevisiae have suggested that IQGAP
plays a key role in linking actin cytoskeletal rearrange- binding of RhoGDI do not affect the binding of other
targets may be related to the indication from the X-rayments to cellular trafficking events and cytokinesis [18].
As shown in Figure 2C (upper panel), the GDI binding- crystallographic structures of different Cdc42 species
[6] that the Switch II domain is not acting like a bonadefective Cdc42(F28L,R66A) double mutant can associ-
ate with IQGAP as read out by immunoprecipitation of fide conformationally sensitive region in Cdc42 and thus
does not function as a target binding domain. We andHA-tagged Cdc42 with anti-HA antibody and subse-
quent Western blotting with a specific anti-IQGAP anti- others have also found that mutating arginine 66 of
Cdc42 does not alter the functional regulation of guaninebody (the lower panel in Figure 2C shows the relative
amounts of the different HA-tagged Cdc42 proteins that nucleotide exchange activity by Dbl-family members
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(data not shown; also [19, 20]). The same holds true for
the GAP-stimulated GTP hydrolytic activity of Cdc42
[21]. Overall, these results suggest that mutating argi-
nine 66 in Cdc42 uniquely interrupts its interaction with
RhoGDI and does not interfere with the binding or func-
tion of other regulatory or target/effector proteins. Given
these findings, we further examined the consequences
of mutating arginine 66 to alanine on the cellular activi-
ties normally triggered by activated Cdc42.
Disruption of Cdc42(F28L)-RhoGDI Interactions
Affects the Cellular Localization of Activated
Cdc42 and Cell Morphology
One of the primary biochemical activities of RhoGDI is
its ability to stimulate the release of Cdc42 and related
Rho GTP binding proteins from membranes. Thus, it
would be expected that by blocking the interactions of
Cdc42 with RhoGDI, one could reduce the cytosolic
levels of Cdc42. Figure 3A shows that this was indeed
the case when the R66A mutation was introduced in an
activated F28L background. The particulate (micro-
somal membrane) and cytosolic fractions from NIH 3T3
cells stably expressing HA-tagged Cdc42(F28L) and HA-
Cdc42(F28L,R66A) were resolved by high-speed centrif-
ugation. As shown in Figure 3A, the Cdc42(F28L,R66A)
protein was completely absent from the cytosolic
(S100K) fraction, as opposed to the case for the
Cdc42(F28L) mutant, suggesting that in the absence
of RhoGDI interactions, activated Cdc42 is associated
exclusively with cellular membranes. A careful examina-
tion of the immunofluorescence profiles for COS-7 cells
that transiently expressed GFP-labeled Cdc42(F28L)
and GFP-Cdc42(F28L,R66A) also suggested that there
was a shift in the overall membrane distribution of
Cdc42, such that the majority of the RhoGDI binding-
defective Cdc42(F28L,R66A) double mutant was perinu-
clear (Figure 3B, lower panel, arrow), whereas the
Cdc42(F28L) protein was perinuclear and was also de-
tected along the outer surface of the cells (Figure 3B,
upper panel, see arrows).
We also have observed cell morphology changes that
were most apparent when we compared NIH 3T3 fibro-
blasts expressing Cdc42(F28L) versus the Cdc42
(F28L,R66A) double mutant. In these cases, a Tet-off
eukaryotic expression system was used to establish
tetracycline-inducible NIH 3T3 cell lines that were trans-
Figure 3. Effects of the R66A Mutation on the Cellular Localizationfected with plasmids encoding wild-type Cdc42, as well
of Activated Cdc42as the Cdc42(R66A), Cdc42(F28L), and Cdc42(F28L,R66A)
(A) NIH 3T3 cells that stably expressed Cdc42(F28L) ormutants. We induced the expression of these different
Cdc42(F28L,R66A) were collected, homogenized, and fractionatedproteins by removing tetracycline from the culture me-
as described in the Experimental Procedures. The particulate (P)
dium (see Figure 4B). Although neither the inducible and the cytosolic fractions (40 g protein/lane) were separated by
expression of wild-type Cdc42 nor that of the centrifugation. Cdc42 protein was detected by immunoblotting with
Cdc42(R66A) mutant in NIH 3T3 cells elicited any obvi- an anti-HA antibody (Babco).
(B) COS-7 cells were transiently transfected with GFP-taggedous effects on cell morphology (data not shown), cells
Cdc42(F28L) or Cdc42(F28L,R66A). The localization of GFP-taggedexpressing Cdc42(F28L) exhibited elongated cell bod-
Cdc42(F28L) or Cdc42(F28L,R66A) was examined with a Leica con-ies, whereas cells expressing the Cdc42(F28L,R66A)
focal microscope.
double mutant were flat and often appeared larger than
either control or Cdc42(F28L)-expressing fibroblasts
(Figure 4A). Some good examples of this are shown in sion complexes with anti-paxillin antibody (bottom pan-
els), respectively. In fact, one of the cells expressingFigure 4C, where Cdc42(F28L)- and Cdc42(F28L,R66A)-
expressing cells were stained for F-actin with rhoda- Cdc42(F28L,R66A) contained two nuclei (Figure 4C). We
had earlier reported that expression of the constitutivelymine-labeled phalloidin (top panels) and for focal adhe-
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Figure 4. Cdc42(F28L,R66A) Induces Morphological Changes in NIH 3T3 Cells
(A) NIH 3T3 cells stably transfected with pTet-Cdc42(F28L) and Cdc42(F28L,R66A) were grown in normal serum with or without tetracycline
for 5 days, and the morphology of the cells was visualized with a Zeiss phase-contrast microscope. Tet, uninduced; -Tet, induced.
(B) Expression of HA-tagged Cdc42(F28L) and Cdc42(F28L,R66A) shown in Figure 4A. The proteins were detected via immunoblotting with
an anti-HA antibody. Tet, uninduced; -Tet, induced.
(C) NIH 3T3 cells that expressed Cdc42(F28L,R66A) or Cdc42(F28L) were fixed and immunostained with Texas-red-conjugated phalloidin (top
panels) or with anti-paxillin (bottom panels).
active Cdc42(F28L) mutant resulted in some cells (typi- as 10% of the cells expressing Cdc42(F28L,R66A) are
multi-nucleate in appearance, and we suspect that bycally approsimately 5%) having multiple nuclei, similar
to what had earlier been described for cells expressing blocking Cdc42-RhoGDI interactions, this phenotype,
which is associated with the expression of hyper-acti-oncogenic Dbl, a GEF for Cdc42 [13] and as opposed
to control NIH 3T3 cells, which typically do not show vated forms of Cdc42, is somehow exaggerated. Although
the Cdc42(F28L,R66A) double mutant, similar to thethis phenotype (1% of the cells). We find that as many
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Cdc42(F28L) mutant, is able to stimulate the formation of changes were similar to those observed in cells that
expressed the RhoGDI binding-defective Cdc42focal complexes (Figure 4C, bottom panels), comparisons
of Cdc42(F28L)- and Cdc42(F28L,R66A)-expressing cells (F28L,R66A) protein (Figure 4A). Changes in the actin
cytoskeletal organization that were qualitatively similarin Figure 4C (top panels) also show what appears to be
a general disorganization of actin stress fibers upon to those described for Cdc42(F28L,R66A)-expressing
cells accompanied expression of the siRNA for RhoGDIexpression of the RhoGDI binding-defective Cdc42 mu-
tant. These changes in cell shape and cytoskeletal ar- (data not shown), although in general these changes
were less pronounced in the siRNA experiments, per-rangement that accompanied the inhibition of the inter-
actions between activated Cdc42 and RhoGDI led us to haps because we did not achieve a complete elimination
of RhoGDI expression. However, we were able to clearlyquestion whether blocking Cdc42-RhoGDI interactions
might also impact Cdc42(F28L)-induced cellular trans- see that the transformation capability of the Cdc42
(F28L) protein in cells expressing reduced levels offormation.
RhoGDI was significantly compromised, as assayed by
colony formation in soft agar (Figures 6C and 6D). Thus,
Cdc42-RhoGDI Interactions Are Required these results verify the importance of RhoGDI for Cdc42-
for Cdc42-Induced Transformation induced cellular transformation.
Our previous studies have shown that expression of
the constitutively active Cdc42(F28L) mutant in NIH 3T3
cells induced cellular transformation and caused tumor Discussion
formation in nude mice [13]. To test the importance of
RhoGDI in Cdc42-mediated cellular transformation, we RhoGDI was originally named for its ability to block the
dissociation of GDP from Rho and related GTP bindingutilized the inducible cell lines expressing the
Cdc42(F28L) and Cdc42(F28L,R66A) mutants that were proteins [2, 4, 23]. Thus, this protein has often been
assumed to act as a negative regulator by inhibitingdescribed in the preceding section. When we used nor-
mal (5%) concentrations of serum in the culture medium, the activation (i.e., GDP-GTP exchange activity) of Rho-
family GTP binding proteins. However, RhoGDI exhibitsthe growth of cells that expressed the activated
Cdc42(F28L) mutant was about 2-fold faster than either two other biochemical activities that are likely to contrib-
ute to its overall regulatory functions. One of these is thecontrol cells or cells expressing the Cdc42(F28L,R66A)
double mutant (Figure 5A). However, when we measured stimulated release of Rho-related GTP binding proteins
from membranes [4, 24]. This function has been tradi-cell growth in low (1%) concentrations of serum, both
control NIH 3T3 cells and cells expressing Cdc42 tionally associated with the early finding that the ability
of RhoGDI to bind to its target GTP binding proteins(F28L,R66A) had arrested growth during the first 24 hr,
followed by a progressive cell death, whereas cells ex- with high affinity requires their isoprenylation [4, 25],
and in fact the X-ray crystallographic structure of thepressing Cdc42(F28L) were able to steadily proliferate,
which is one hallmark of cellular transformation (Fig- Cdc42-RhoGDI complex shows that the GDI contains a
substantial hydrophobic binding pocket for the geranyl-ure 5B).
We also examined the abilities of these different cell geranyl moiety of Cdc42 [6]. A second activity is that
unlike the RabGDIs, which also extract Rab proteinslines to grow in soft agar because this has often been
considered to be the most reliable indicator of cellular from membranes but bind with high selectivity to the
GDP bound form of the Rabs, the RhoGDI can bind withtransformation. As shown in Figures 5C and 5D, NIH
3T3 cells that expressed the constitutively active essentially equal affinity to the GDP and GTP bound
forms of Cdc42 [11] and is capable of inhibiting the GTPCdc42(F28L) protein exhibited anchorage-independent
growth, consistent with what we had earlier reported hydrolytic activity of Cdc42 [3]. Thus, these multiple
biochemical activities exhibited by RhoGDI expand its[13], whereas, similar to the control cells, cells express-
ing the Cdc42(F28L,R66A) double mutant were unable potential repertoire of regulatory roles in cells.
In the present study, we describe the surprising find-to form colonies in soft agar. Taken together, the results
presented in Figure 5 strongly suggested that Cdc42- ing that the interaction of activated Cdc42 with RhoGDI
is essential for Cdc42-mediated cellular transformation.RhoGDI interactions were in fact essential for Cdc42-
mediated cellular transformation. To our knowledge, this is the first demonstration of a
positive (rather than negative) regulatory role for the GDIHowever, in order to rule out the possibility that the
transformation defects exhibited by the Cdc42(F28L,R66A) in cell growth control. In making these findings, we first
took advantage of the X-ray-crystallographic structuredouble mutant were due to an inability of this activated
Cdc42 protein to bind to an as-yet-unidentified target for the Cdc42-RhoGDI complex to generate Cdc42 mu-
tants that were specifically defective in their ability to(which would presumably be essential for transforma-
tion), we set out to reduce the levels of endogenous bind the GDI while maintaining their binding affinity for
other known targets and regulatory proteins. In particu-RhoGDI by using small inhibitory RNA (siRNA) ap-
proaches [22]. As shown in Figure 6A, we have been lar, we changed Cdc42 Switch II domain residues (i.e.,
arginine 66 or 68) that engage an amino terminal helicalable to reduce the levels of endogenous RhoGDI by at
least 50% (ranging from approximately 50%–75%) upon arm of RhoGDI that is essential for the first step in the
Cdc42-RhoGDI interaction. We found that when we di-transfecting fibroblasts with RhoGDI siRNA. This reduc-
tion in the levels of endogenous RhoGDI was accompa- rectly compared the abilities of the constitutively active
Cdc42(F28L) mutant and the constitutively active butnied by detectable changes in the morphology of cells
expressing the Cdc42(F28L) mutant (Figure 6B); these RhoGDI binding-defective Cdc42(F28L,R66A) to trans-
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Figure 5. Binding to RhoGDI Is Required for Cdc42-Stimulated Cell Growth and Transformation
(A) The growth rate of NIH 3T3 cells stably transfected with Cdc42(F28L) or Cdc42(F28L,R66A) and cultured at normal concentrations (5%)
of calf serum. Tet, uninduced; -Tet, induced.
(B) The growth rate of the indicated cell lines that were cultured at a low concentration (1%) of calf serum. Tet, uninduced; -Tet, induced.
(C) Anchorage-independent growth of Cdc42(F28L)- and Cdc42(F28L,R66A)-expressing cells. Anchorage-independent growth was determined
by an assay of colony formation in soft agar. The cells were cultured in the medium with or without tetracycline for 24 hr before being plated
on soft agar. Tet, uninduced; -Tet, induced.
(D) Quantification of colony formation on soft agar. Colonies were scored after 14 days of growth on soft agar as shown in Figure 5C. In each
experiment, three duplicate 35 mm plates were counted at three randomly chosen areas.
form NIH 3T3 cells under conditions where these pro- the expression of the GDI gave rise to a corresponding
reduction in transformation activity.teins were expressed to identical levels, only the
Cdc42(F28L) protein was capable of inducing a trans- How might RhoGDI contribute to the signaling func-
tion of Cdc42 such that Cdc42-RhoGDI interactions areformed phenotype. As further support for the essential
role of RhoGDI in Cdc42-mediated cellular transforma- essential for Cdc42-mediated transformation? Clearly,
the levels and functional activities of this regulatory pro-tion, we used siRNA approaches to show that reducing
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Figure 6. Reduction in the Levels of Endogenous RhoGDI Influences Cdc42(F28L)-Mediated Effects on Cell Morphology and Cellular Transfor-
mation
After 48 hr of transfection with control oligomer or RhoGDI siRNA, NIH 3T3 cells were examined for morphology changes and were plated
on soft agar to assay for anchorage-independent growth. Colonies were scored after 6–7 days incubation in soft agar. A 21-oligomer of DNA
generated from the coding region of the tyrosine kinase domain of ACK2, or a siRNA that has no complete sequence match in the GenBank
database, was used as a control for the RhoGDI siRNA transfections. Both controls gave no phenotype when expressed in NIH 3T3 cells.
(A) The expression of endogenous RhoGDI in control NIH 3T3 cells and in Cdc42(F28L)-expressed cells that were transfected 48 hr with either
the 21 bp DNA oligomer or RhoGDI siRNA was assessed with an anti-RhoGDI antibody from Transduction Laboratories.
(B) Cell morphology of NIH 3T3 cells expressing Cdc42(F28L) transfected with control dsRNA and RhoGDI siRNA.
(C) Top panel: colonies formed after 6–7 days of culturing Cdc42(F28L)  control 21 bp DNA oligomer-transfected cells in soft-agar medium.
Bottom panel: colonies formed after 6–7 days of culturing Cdc42(F28L)  RhoGDI siRNA-transfected cells in soft-agar medium.
(D) Quantification of colony formation in soft agar for the experiments shown in Figure 6C.
tein need to be carefully regulated and balanced be- activation. Moreover, it appears blocking Cdc42-
RhoGDI interactions accentuates a cellular phenotypecause the excessive expression of RhoGDI would be
expected to inhibit cell growth through its ability to in- associated with the hyperactivation of Cdc42 (multi-
nucleate cells). However, despite the potential role forhibit the dissociation of GDP from Cdc42 and other Rho-
related GTP binding proteins and thus antagonize their RhoGDI in negatively regulating the activation of Rho
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proteins, the ability of this regulatory protein to confer protein) can be toxic to NIH 3T3 cells. The interactions
of RhoGDI with activated forms of Cdc42, which stabilizea positive contribution to signaling responses is not
without precedent; the Rac-RhoGDI complex was ini- the active state by blocking GTP hydrolysis, must there-
fore be of a finite duration in cells if the GDI is to havetially identified to be essential for the stimulatory regula-
tion of the NADPH oxidase system in neutrophils [26– a positive impact on Cdc42-mediated growth and trans-
formation. However, this would be consistent with the28], implying that RhoGDI somehow properly presents
Rac to the NADPH oxidase in membranes to enable idea that RhoGDI shuttles activated Cdc42 to specific
membrane sites, disengages, and thus allows Cdc42optimal Rac-stimulated oxidase activity. For membrane
transport systems involving the Rab proteins, it has also to bind to target/effectors and ultimately to GAPs. By
cycling between different membrane locations and di-been established that RabGDI has an important role in
shuttling the Rab proteins between intracellular mem- recting the movement of Cdc42 molecules to distinct
cellular sites, a single GDI molecule might then be capa-brane sites in order to ensure vectorial transport activity
[29, 30]. Thus, it seems reasonable to envisage a similar ble of mediating the proper localization of multiple
Cdc42 molecules. Finally, perhaps the most attractivetype of role for RhoGDI in “presenting” Cdc42 to impor-
tant membrane-associated target/effectors, particularly feature of this general model stems from the earlier
finding that Cdc42--coatomer interactions are essen-because we and others have shown that Cdc42 is pres-
ent in and signals from both the plasma membrane and tial for the transforming signal [17]. This led to the con-
clusion that the participation of Cdc42 in some typethe Golgi [17]. We find that the GDI binding-defective
Cdc42(F28L,R66A) mutant is exclusively membrane- of cellular transport activity was linked to its ability to
transform cells. Thus, RhoGDI, by acting in a mannerassociated and not detected in the cytosol. It also was
recently shown that another GDI binding-defective mu- analogous to RabGDI, may play an important role in a
transport function and in this way serve as an essentialtant [Cdc42(R66E)], similar to the mutant described in
this study, was not able to be translocated from the regulator of the transforming activity of Cdc42.
Golgi apparatus to the cytosol, as is typically observed
Experimental Procedureswith wild-type Cdc42 [21]. Moreover, we have observed
what appears to be a shift in the membrane distribution
Plasmid Construction and Mutagenesisof Cdc42(F28L,R66A) relative to Cdc42(F28L), such that Cdc42 mutants Cdc42(R66A), Cdc42(F28L,R66A), Cdc42(R68A),
the GDI binding-defective Cdc42 mutant accumulated in and Cdc42(F28L,R68A) were prepared by PCR with the Rapid-site
the Golgi and was less detectable along the cell surface mutagenesis kit (Strategene). The pTet wild-type Cdc42 and pTet
Cdc42(F28L) constructs were generated by subcloning of the cDNAcompared to its Cdc42(F28L) counterpart.
fragment that encodes HA-tagged wild-type Cdc42 or theThus, when taken together with the known role for
Cdc42(F28L) mutant into the Hind III and EcoR V sites of the pTet-RabGDI in directing the proper membrane targeting of
Splice vector (Life Technologies). Other plasmids and mutants wereRab GTP binding proteins, these observations raise the made as described previously [13].
intriguing possibility that in a similar fashion, RhoGDI
needs to shuttle Cdc42 between the Golgi and other Cell Culture and Transfection
cellular (membrane) sites in order to mediate Cdc42- NIH 3T3 cells were cultured in DMEM plus 10% calf serum (CS) at
37C with 5% CO2. COS-7 cells were cultured in DMEM plus 10%signaling activities that impact cell growth and transfor-
fetal bovine serum (FBS) at 37C with 5% CO2. For transient transfec-mation. There are a number of attractive aspects to this
tions, the cells were split at 2  105 in a 60 mm dish, 18 hr beforemodel. One stems from the fact that RhoGDI can bind
transfection. The transfections were performed with the Superfect
to and help maintain the activated state of Cdc42. It transfection kit (Qiagen) according to the manufacturer’s protocol.
seems likely that it is the rather unusual nature of the We prepared cell lysates 48 hr after transfection by lysing the cells
Switch II domain of Cdc42 (and presumably other Rho- with a buffer that contains 40 mM HEPES (pH 7.4), 100 mM NaCl,
1% Triton X-100, 25 mM -glycerolphosphate, 1 mM sodium ortho-related proteins) that underlies the ability of RhoGDI to
vanadate, 1 mM EDTA, and 10g/ml each of leupeptin and aprotinin.bind activated forms of Cdc42. Although the Switch II
domain of Ras was originally identified because it is
Tetracycline-Inducible Cell Linesconformationally sensitive to guanine nucleotides (i.e.,
The tetracycline-inducible cell lines were generated by cotransfec-
it undergoes a structural change upon the exchange of tion of pTet constructs with the activator plasmid (pTAK) and puro-
bound GDP for GTP [31]) and has been shown to be mycin-resistant plasmid into NIH 3T3 cells. After transfection, the
especially important for the recognition of upstream ac- cells were cultured in DMEM plus 10% CS and 1 g/ml tetracycline.
The selection of puromycin-resistant cell colonies was carried outtivators (GEFs), the corresponding region in Cdc42 ap-
48 hr after transfection by addition of 5 g/ml puromycin in thepears to exhibit little change between different guanine
culture medium. The cell colonies resistant to puromycin were se-nucleotide bound states [6, 7, 32]. We had earlier pro-
lected and subcultured in DMEM plus 10% CS, 1 g/ml tetracycline
posed that the minimal changes associated with Switch and 5 g/ml puromycin. The expression of proteins was induced
II may account for the similar affinities of the two guanine by removal of tetracycline from the culture medium for 18–48 hr.
nucleotide bound states of Cdc42 for the GDI [6]. The
ability of RhoGDI to recognize the activated state of Expression and Purification of GST Fusion Proteins and GST
Fusion Protein Precipitation AssaysCdc42, combined with its ability to remove activated
Expression and purification of GST fusion proteins were performedforms of Cdc42 from the membrane, may provide a
as described previously [13, 17]. For binding assays using GSTmeans for coordinating Cdc42-dependent activation of
fusion proteins, the immobilized GST fusion proteins (40 g) ontarget/effectors at different membrane locations. When
glutathione-agarose beads were incubated with mammalian cell ly-
one considers such a role for RhoGDI, it is important sates for 2 hr at 4C with rotation, then the beads were washed (3)
to realize that the persistent activation of Cdc42 (for with bacterial lysis buffer containing 20 mM Tris (pH 8.0), 100 mM
NaCl, 1% Triton X-100, 1 mM EDTA, and 1 mM EGTA. The proteinsexample, as exhibited by GTPase-defective forms of the
Current Biology
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precipitated from the lysates were visualized by Western blot R.A. (1998). Structures of Cdc42 bound to the active and catalyt-
ically compromised forms of Cdc42GAP. Nat. Struct. Biol. 5,analysis.
The JNK assays and soft-agar colony formation were performed 1047–1052.
8. Mott, H.R., Owen, D., Nietlispach, D., Lowe, P.N., Manser, E.,as described previously [13, 17].
Lim, L., and Laue, E.D. (1999). Structure of the small G protein
Cdc42 bound to the GTPase-binding domain of ACK. NatureInhibition of Expression of Endogenous RhoGDI
399, 384–388.by Transfection with RhoGDI siRNA
9. Abdul-Manan, N., Aghazadeh, B., Liu, G.A., Majumdar, A., Ouer-The 21-nucleotide siRNA sequence corresponding to the coding
felli, O., Siminovitch, K.A., and Rosen, M.K. (1999). Structure ofregion between nucleotides 96 and 117 of the mouse RhoGDI was
Cdc42 in complex with the Wiskott-Aldrich syndrome protein.chemically synthesized (Dharmacon). Transfection of the siRNA (fi-
Nature 399, 379–383.nal concentration: 40 nM) for targeting RhoGDI was carried out with
10. Garrard, S.M., Capaldo, C.T., Gao, L., Rosen, M.K., Macara, I.G.,LipofectAmine (BRL). Transfection efficiencies were 70%–90%, as
and Tomchick, D.R. (2003). Structure of Cdc42 in a complexdetermined by Western blot analysis. Control oligomers represented
with the GTPase-binding domain of the cell polarity protein,either a 21-oligomer of DNA generated from the coding region of
Par6. EMBO J. 22, 1125–1133.the tyrosine kinase domain of ACK2 or a siRNA that lacks a complete
11. Nomanbhoy, T.K., and Cerione, R.A. (1996). Characterization ofsequence match in the GenBank database (with the closest match
the interaction between RhoGDI and Cdc42Hs using fluores-being a two base mismatch to the bovine ACK2 sequence).
cence spectroscopy. J. Biol. Chem. 271, 10004–10009.
12. Hart, M.J., Eva, A., Zangrilli, D., Aaronson, S.A., Evans, T., Ceri-Immunofluorescent Staining
one, R.A., and Zheng, Y. (1994). Cellular transformation andThe lipofectamine transfection kit (Invitrogene) was used for tran-
guanine nucleotide exchange activity are catalyzed by a com-siently transfecting COS-7 cells with pEGFP-Cdc42 mutants. Cells
mon domain on the DBL oncogene product. J. Biol. Chem. 269,were plated on chamber slides (Falcon) 24 hr after transfection.
62–65.After subculture for 24 hr, the cells were fixed and then immuno-
13. Lin, R., Bagrodia, S., Cerione, R., and Manor, D. (1997). A novelstained [13, 17]. The GFP fluorescence of the cells was visualized
Cdc42Hs mutant induces cellular transformation. Curr. Biol. 7,with a Leica DM1RE2 inverted confocal microscope, and the images
794–797.were captured and analyzed with Leica confocal Software. Immuno-
14. Bagrodia, S., De´rijard, B., Davis, R.J., and Cerione, R.A. (1995).fluorescence experiments were performed on NIH 3T3 cells stably
Cdc42 and PAK-mediated signaling leads to JNK and p38 Mapexpressing different Cdc42 constructs as previously described [33].
kinase activation. J. Biol. Chem. 270, 27995–27998.
15. Hart, M.J., Callow, M.G., Souza, B., and Polakis, P. (1996). IQ-Membrane Fractionation Analysis
GAP1, a calmodulin-binding protein with a ras-GAP-related do-NIH 3T3 cells stably expressing HA-tagged Cdc42(F28L) and HA-
main, is a potential effector for Cdc42Hs. EMBO J. 15, 2997–Cdc42(F28L,R66A) were washed with ice-cold PBS and collected
3005.via scrapping in ice-cold HYPO buffer (10 mM Tris [pH 7.4], 1 mM
16. Erickson, J.W., Cerione, R.A., and Hart, M.J. (1997). Identifica-MgCl2, 5 g/ml leupeptin, and 5 g/ml aprotinin). The cells were tion of an actin cytoskeletal complex that includes IQGAP andhomogenized with an eppendorf tube homogenizer, and the homog-
the Cdc42 GTPase. J. Biol. Chem. 272, 2443–2447.enates were fractionated by centrifugation. Nuclei and unlysed cells
17. Wu, W.J., Erickson, J.W., Lin, R., and Cerione, R.A. (2000). Thewere separated from the remainder of the homogenate by centrifu-
gamma-subunit of the coatomer complex binds Cdc42 to medi-
gation at 2000  g for 5 min at 4C. The cytosol and microsomal
ate transformation. Nature 405, 800–804.
membrane fractions were separated by high-speed centrifugation
18. Osman, M.A., Konopka, J.B., and Cerione, R.A. (2002). Iqg1p
(100,000  g for 30 min at 4C). The pellets were resuspended in
links spatial and secretion landmarks to polarity and cytokine-
SDS-PAGE sample buffer, and the Cdc42 proteins were detected
sis. J. Cell Biol. 159, 601–611.
by Western blot with an anti-HA antibody.
19. Li, R., and Zheng, Y. (1997). Residues of the Rho family GTPases
Rho and Cdc42 that specify sensitivity to Dbl-like guanine nucle-
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